These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34168648)

  • 1. Integrative Multi-Omics Reveals Serum Markers of Tuberculosis in Advanced HIV.
    Krishnan S; Queiroz ATL; Gupta A; Gupte N; Bisson GP; Kumwenda J; Naidoo K; Mohapi L; Mave V; Mngqibisa R; Lama JR; Hosseinipour MC; Andrade BB; Karakousis PC
    Front Immunol; 2021; 12():676980. PubMed ID: 34168648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study.
    Akanbi MO; Achenbach C; Taiwo B; Idoko J; Ani A; Isa Y; Agbaji O; Ukoli C; Akande P; Maiga M; Murphy RL
    BMC Pulm Med; 2017 May; 17(1):87. PubMed ID: 28558662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
    Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
    BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insufficient tuberculosis treatment leads to earlier and higher mortality in individuals co-infected with HIV in southern China: a cohort study.
    Zheng Z; Nehl EJ; Zhou C; Li J; Xie Z; Zhou Z; Liang H
    BMC Infect Dis; 2020 Nov; 20(1):873. PubMed ID: 33225919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
    Hosseinipour MC; Bisson GP; Miyahara S; Sun X; Moses A; Riviere C; Kirui FK; Badal-Faesen S; Lagat D; Nyirenda M; Naidoo K; Hakim J; Mugyenyi P; Henostroza G; Leger PD; Lama JR; Mohapi L; Alave J; Mave V; Veloso VG; Pillay S; Kumarasamy N; Bao J; Hogg E; Jones L; Zolopa A; Kumwenda J; Gupta A;
    Lancet; 2016 Mar; 387(10024):1198-209. PubMed ID: 27025337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV.
    Machowski EE; Letutu M; Lebina L; Waja Z; Msandiwa R; Milovanovic M; Gordhan BG; Otwombe K; Friedrich SO; Chaisson R; Diacon AH; Kana B; Martinson N
    BMC Infect Dis; 2021 May; 21(1):466. PubMed ID: 34022850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and predictors of tuberculosis occurrence among adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: retrospective follow-up study.
    Aemro A; Jember A; Anlay DZ
    BMC Infect Dis; 2020 Mar; 20(1):245. PubMed ID: 32216747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment.
    Dierberg KL; Chaisson RE
    Clin Chest Med; 2013 Jun; 34(2):217-28. PubMed ID: 23702172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective Diagnostic Accuracy Study of Abbott RealTi
    Howlett P; Nabeta P; Tukvadze N; Schumacher SG; Denkinger CM
    Microbiol Spectr; 2021 Sep; 9(1):e0013221. PubMed ID: 34406811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study.
    Namugenyi J; Musaazi J; Katamba A; Kalyango J; Sendaula E; Kambugu A; Fehr J; Castelnouvo B; Manabe YC; Ssengooba W; Sekaggya-Wiltshire C
    BMC Infect Dis; 2021 Jun; 21(1):513. PubMed ID: 34074248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of microRNA miR-16 and miR-155 are altered in serum of patients with tuberculosis and associate with responses to therapy.
    Wagh V; Urhekar A; Modi D
    Tuberculosis (Edinb); 2017 Jan; 102():24-30. PubMed ID: 28061948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.
    Lawn SD; Kerkhoff AD; Vogt M; Wood R
    Lancet Infect Dis; 2012 Mar; 12(3):201-9. PubMed ID: 22015305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and identification of four serum miRNAs as novel potential biomarkers for cured pulmonary tuberculosis.
    Wang C; Yang S; Liu CM; Jiang TT; Chen ZL; Tu HH; Mao LG; Li ZJ; Li JC
    Tuberculosis (Edinb); 2018 Jan; 108():26-34. PubMed ID: 29523324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of tuberculosis infection among adults visiting anti-retroviral treatment center at east and west Gojjam, northwest, Ethiopia, 2017.
    Belew H; Wubie M; Tizazu G; Bitew A; Birlew T
    BMC Infect Dis; 2020 Aug; 20(1):593. PubMed ID: 32787798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study.
    Sekaggya-Wiltshire C; Castelnuovo B; von Braun A; Musaazi J; Muller D; Buzibye A; Gutteck U; Henning L; Ledergerber B; Corti N; Lamorde M; Fehr J; Kambugu A
    BMJ Open; 2017 Sep; 7(9):e014679. PubMed ID: 28928173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying quantitative sncRNAs signature using global sequencing as a potential biomarker for tuberculosis diagnosis and their role in regulating host response.
    Kaul S; Nair V; Gcanga L; Lakshmanan V; Kalamuddin M; Anang V; Rathore S; Dhawan S; Alam T; Khanna V; Lohiya S; Ali S; Mannan S; Rade K; Parihar SP; Khanna A; Malhotra P; Brombacher F; Dasaradhi PV; Guler R; Mohmmed A
    Int J Biol Macromol; 2024 Jun; 271(Pt 2):132714. PubMed ID: 38815937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.
    Walusimbi S; Kwesiga B; Rodrigues R; Haile M; de Costa A; Bogg L; Katamba A
    BMC Health Serv Res; 2016 Oct; 16(1):563. PubMed ID: 27724908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.